CD8A and melanoma: A study by Scheper et al. (33) has assessed the intrinsic tumor reactivity of TILs in melanoma and ovarian and colorectal cancer, demonstrating how indeed only a small fraction of the intratumoral CD8+ T-cell receptor (TCR) repertoire is able to recognize autologous cancer cells.